Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

Similar Items

• Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
  od: Robson, M, i dr.
  Izdano: (2002)
• Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
  od: Kadouri, Luna, i dr.
  Izdano: (2007)
• Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
  od: Hodgson, S., i dr.
  Izdano: (1999)
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
  od: Levy-Lahad, E, i dr.
  Izdano: (1997)
• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
  od: Friedman, E, i dr.
  Izdano: (1998)